As neurosurgeons, preoperative risk assessment now extends beyond traditional anticoagulants. With the expanding use of targeted oncologic therapies, understanding their effects on wound healing, radiation response, and intracranial hemostasis is critical to optimizing outcomes.
ALT Featured publication image of Perioperative Management of Targeted and Immunologic Agents in Neurosurgical Oncology.